Breakthrough in Treatment of Cervical High-Grade Squamous Intraepithelial Lesion: Release of Positive Results from Multicenter Phase III Global Clinical Study
The world’s first non-surgical cervical HSIL treatment validated by an international Phase…
Global X ETFs Introduces Global X India Select Top 10 ETF (3184) and Pioneering Global X K-pop and Culture ETF (3158): Access High-Growth Markets and Unlock Unique Investment Opportunities
HONG KONG, March 19, 2024 /PRNewswire/ — Global X ETFs, a leading…